Imunon’s Phase III-stage IL-12 gene therapy alters tumour microenvironment in ovarian cancer
Translational results bolster confidence as Phase III trial for IMNN-001 in advance epithelial ovarian cancer gets underway.
Cell & Gene Therapy
Sartorius to invest $3m for minority share in biotech start-up Nanotein
JCR Pharma and Alexion partner on JUST-AAV gene therapy platform
Inborn errors of metabolism elicit unique challenges for therapy development
Broader population could benefit from Novartis spinal muscular atrophy treatment
Cartesian shares updated Phase IIb Descartes-08 data and announces Phase III trial plans
FDA shares additional draft guidance on CGTs
Lyell goes all in on CAR-T therapies, buys ImmPACT Bio and trims pipeline
